Disclosure 0001193125-26-352523-2

SEC FORM 4

$607,800.00

Cullinan Therapeutics, Inc. (CGEM)

Sale of 30,000 shares at $20.26 per share.

Reporting Person Michaelson Jennifer · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001193125-26-352523 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Cullinan Therapeutics, Inc. (CGEM)." Disclosed 2026-08-14. https://desqlong.com/cards/0001193125-26-352523-2 (retrieved 2026-09-26).